phase 1_completion
saveOno Pharmaceutical Co Ltd — ONO-4578 (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Hormone Sensitive Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer